Quince Therapeutics, Inc. (QNCX) Stock Total Returns
Growth of $10,000 chart
2026-01-29 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,815
Total Return
-61.85%
CAGR
-94.02%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -6.05% |
| Median | -12.97% |
| Best | +71.03% |
| Worst | -82.46% |
| % of Windows Positive | 36.4% |
1-Year (252 Trading Days)
3-Year (756 Trading Days)
Risk Metrics
| Maximum Drawdown | -86.89% |
| Average Drawdown | -74.33% |
| Drawdown Duration | 77 Trading Days (Unrecovered) |
| Sortino Ratio | 3.06 |
| Calmar Ratio | -1.08 |
| CVaR (5%) | -34.62% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -61.85% (-94.02% ann.) | $6185.19 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | January 29, 2026 – June 3, 2026 | -61.85% | -94.02% | $6185.19 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.